Annual Cash & Cash Equivalents
$114.31 M
+$2.73 M+2.44%
31 December 2021
Summary:
BioDelivery Sciences International annual cash & cash equivalents is currently $114.31 million, with the most recent change of +$2.73 million (+2.44%) on 31 December 2021. During the last 3 years, it has risen by +$2.73 million (+2.44%).BDSI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$114.31 M
+$13.60 M+13.50%
31 December 2021
Summary:
BioDelivery Sciences International quarterly cash and cash equivalents is currently $114.31 million, with the most recent change of +$13.60 million (+13.50%) on 31 December 2021.BDSI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDSI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +2.4% | +13.5% |
| 5 y5 years | +160.8% | +104.6% |
BDSI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -4.6% |
BioDelivery Sciences International Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $114.31 M(+2.4%) | $114.31 M(+13.5%) |
| Sept 2021 | - | $100.71 M(-16.0%) |
| June 2021 | - | $119.85 M(+2.9%) |
| Mar 2021 | - | $116.44 M(+4.3%) |
| Dec 2020 | $111.58 M(+74.7%) | $111.58 M(+11.4%) |
| Sept 2020 | - | $100.18 M(+10.1%) |
| June 2020 | - | $91.01 M(+28.9%) |
| Mar 2020 | - | $70.61 M(+10.5%) |
| Dec 2019 | $63.89 M(+45.8%) | $63.89 M(+14.4%) |
| Sept 2019 | - | $55.86 M(-2.4%) |
| June 2019 | - | $57.22 M(+38.4%) |
| Mar 2019 | - | $41.33 M(-5.7%) |
| Dec 2018 | $43.82 M(+106.8%) | $43.82 M(-11.4%) |
| Sept 2018 | - | $49.48 M(-11.2%) |
| June 2018 | - | $55.72 M(+360.9%) |
| Mar 2018 | - | $12.09 M(-43.0%) |
| Dec 2017 | $21.20 M(-33.8%) | $21.20 M(+7.3%) |
| Sept 2017 | - | $19.75 M(-28.2%) |
| June 2017 | - | $27.51 M(-21.9%) |
| Mar 2017 | - | $35.22 M(+10.0%) |
| Dec 2016 | $32.02 M(-61.7%) | $32.02 M(-28.3%) |
| Sept 2016 | - | $44.68 M(-22.2%) |
| June 2016 | - | $57.46 M(-17.2%) |
| Mar 2016 | - | $69.39 M(-17.0%) |
| Dec 2015 | $83.56 M(+18.6%) | $83.56 M(+53.5%) |
| Sept 2015 | - | $54.43 M(-19.5%) |
| June 2015 | - | $67.66 M(+6.6%) |
| Mar 2015 | - | $63.46 M(-10.0%) |
| Dec 2014 | $70.47 M(+204.1%) | $70.47 M(-17.9%) |
| Sept 2014 | - | $85.79 M(+9.5%) |
| June 2014 | - | $78.36 M(-11.2%) |
| Mar 2014 | - | $88.20 M(+280.6%) |
| Dec 2013 | $23.18 M(-63.3%) | $23.18 M(-39.5%) |
| Sept 2013 | - | $38.30 M(+2.3%) |
| June 2013 | - | $37.43 M(-24.6%) |
| Mar 2013 | - | $49.67 M(-21.4%) |
| Dec 2012 | $63.19 M(+487.8%) | $63.19 M(+101.8%) |
| Sept 2012 | - | $31.32 M(-27.2%) |
| June 2012 | - | $43.03 M(+34.0%) |
| Mar 2012 | - | $32.12 M(+198.7%) |
| Dec 2011 | $10.75 M | $10.75 M(-28.9%) |
| Sept 2011 | - | $15.12 M(-28.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | - | $21.19 M(-19.2%) |
| Mar 2011 | - | $26.22 M(+44.0%) |
| Dec 2010 | $18.21 M(-23.7%) | $18.21 M(-17.8%) |
| Sept 2010 | - | $22.16 M(-11.8%) |
| June 2010 | - | $25.12 M(+46.8%) |
| Mar 2010 | - | $17.11 M(-28.3%) |
| Dec 2009 | $23.87 M(+2535.9%) | $23.87 M(-7.7%) |
| Sept 2009 | - | $25.87 M(+423.8%) |
| June 2009 | - | $4.94 M(+84.1%) |
| Mar 2009 | - | $2.68 M(+196.2%) |
| Dec 2008 | $905.70 K(-93.4%) | $905.70 K(-53.8%) |
| Sept 2008 | - | $1.96 M(-68.0%) |
| June 2008 | - | $6.12 M(-38.6%) |
| Mar 2008 | - | $9.97 M(-27.7%) |
| Dec 2007 | $13.80 M(+535.2%) | $13.80 M(-33.5%) |
| Sept 2007 | - | $20.75 M(+1159.2%) |
| June 2007 | - | $1.65 M(+22.2%) |
| Mar 2007 | - | $1.35 M(-37.9%) |
| Dec 2006 | $2.17 M(-55.8%) | $2.17 M(-46.8%) |
| Sept 2006 | - | $4.09 M(-22.0%) |
| June 2006 | - | $5.24 M(+23.0%) |
| Mar 2006 | - | $4.26 M(-13.3%) |
| Dec 2005 | $4.91 M(+555.4%) | $4.91 M(+3666.1%) |
| Sept 2005 | - | $130.50 K(-92.7%) |
| June 2005 | - | $1.79 M(+37.1%) |
| Mar 2005 | - | $1.31 M(+74.1%) |
| Dec 2004 | $749.90 K(+42.6%) | $749.90 K(-65.0%) |
| Sept 2004 | - | $2.14 M(+1398.9%) |
| June 2004 | - | $142.80 K(-50.3%) |
| Mar 2004 | - | $287.50 K(-45.3%) |
| Dec 2003 | $525.70 K(-89.9%) | $525.70 K(-54.6%) |
| Sept 2003 | - | $1.16 M(-54.1%) |
| June 2003 | - | $2.52 M(+7.7%) |
| Mar 2003 | - | $2.34 M(-55.0%) |
| Dec 2002 | $5.21 M(+6797.1%) | $5.21 M(-18.4%) |
| Sept 2002 | - | $6.38 M(-17.3%) |
| June 2002 | - | $7.72 M(>+9900.0%) |
| Mar 2002 | - | $0.00(-100.0%) |
| Dec 2001 | $75.50 K(-92.1%) | $75.50 K(-40.5%) |
| Sept 2001 | - | $126.90 K(-2.0%) |
| June 2001 | - | $129.50 K(-78.1%) |
| Mar 2001 | - | $591.10 K |
| Dec 2000 | $950.90 K | - |
FAQ
- What is BioDelivery Sciences International annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioDelivery Sciences International?
- What is BioDelivery Sciences International quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioDelivery Sciences International?
What is BioDelivery Sciences International annual cash & cash equivalents?
The current annual cash & cash equivalents of BDSI is $114.31 M
What is the all time high annual cash & cash equivalents for BioDelivery Sciences International?
BioDelivery Sciences International all-time high annual cash & cash equivalents is $114.31 M
What is BioDelivery Sciences International quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BDSI is $114.31 M
What is the all time high quarterly cash and cash equivalents for BioDelivery Sciences International?
BioDelivery Sciences International all-time high quarterly cash and cash equivalents is $119.85 M